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IjB kinase a (IKKa), one of the two catalytic subunits of
the IKK complex involved in nuclear factor jB (NF-jB)
activation, also functions as a molecular switch that con-
trols epidermal differentiation. This unexpected function
requires IKKa nuclear translocation but does not depend
on its kinase activity, and is independent of NF-jB signal-
ling. Ikka
–/– mice present with a hyperproliferative and
undifferentiated epidermis characterized by complete
absence of a granular layer and stratum corneum. Ikka-
deﬁcient keratinocytes do not express terminal differentia-
tion markers and continue to proliferate even when
subjected to differentiation-inducing stimuli. This antipro-
liferative function of IKKa is also important for the sup-
pression of squamous cell carcinogenesis. The exact
mechanisms by which nuclear IKKa controls keratinocyte
proliferation and differentiation remained mysterious for
some time. Recent studies, however, have revealed that
IKKa is a major cofactor in a TGFb–Smad2/3 signalling
pathway that is Smad4 independent. This pathway con-
trols cell cycle withdrawal during keratinocyte terminal
differentiation. Although these are not the only functions
of nuclear IKKa, this multifunctional protein is a key
regulator of keratinocyte and epidermal differentiation
and a critical suppressor of skin cancer.
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Introduction
The epidermis, the outermost part of the skin, is a stratiﬁed
and keratinized squamous epithelium mainly composed of
keratinocytes, which forms a protective barrier. Epidermal
differentiation, which starts in the mouse at embryonic day
(E) 12, leads to formation of several distinct cell layers
characterized by their ultrastructure, mitotic state and ex-
pression of speciﬁc molecular markers (Fuchs and Byrne,
1994; Koster and Roop, 2007). The basal layer develops from
the surface ectoderm at approximately E9.5 in the mouse.
The p63 gene, which speciﬁes different isoforms of a tran-
scription factor related to tumour suppressor p53, controls
basal layer formation and maintenance as well as IkB kinase
a (IKKa) expression (Candi et al, 2007; Koster et al, 2007).
Basal keratinocytes, including epidermal stem cells and tran-
sit-amplifying cells, are cuboidal, express cytokeratins (CKs)
5 and 14 and have a high proliferative potential (Koster and
Roop, 2007). These cells form the embryonic periderm
(M’Boneko and Merker, 1988), which is lost on establishment
of the epidermal barrier. At E12 in the mouse, the basal cells
give rise to the intermediate cell layer located between the
embryonic basal layer and the periderm (Smart, 1970; Weiss
and Zelickson, 1975). The intermediate cells divide several
times before they withdraw from cell cycle and mature into
postmitotic spinous cells (Smart, 1970; Koster and Roop,
2007). By contrast, adult basal keratinocytes directly become
spinous cells when terminal differentiation is initiated, with-
out involvement of an intermediate cell type (Koster and
Roop, 2007). The spinous layer is characterized by a switch in
keratin expression, from CK5 and CK14 to CK1 and CK10
(Fuchs and Green, 1980). Involucrin, a marker of early
terminal differentiation is also synthesized in the upper part
of this layer. The spinous cells continue their differentiation
and maturation to form the granular layer, which is char-
acterized by keratohyalin granules and expression of the late
differentiation markers loricrin and ﬁlaggrin (Candi et al,
2005). Terminal differentiation gives rise to the corniﬁed layer
(stratum corneum), which consists of extremely ﬂat, keratin-
ﬁlled and anucleated keratinocytes, called corneocytes,
which are mummiﬁed within a lipid matrix (Candi et al,
2005; Segre, 2006). The stratum corneum is primarily respon-
sible for the barrier function of the skin (Elias, 2004; Segre,
2006), which is established around E17.5 in mouse (Hardman
et al, 1998). Although major progress has been made in
understanding the molecular changes that characterize epi-
dermal differentiation, less is known about the signalling
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2639pathways that control these events. Here, we provide an
overview of the current understanding of the central function
of IKKa in the control of epidermal differentiation, homo-
eostasis and tumorigenesis.
Defective epidermal morphogenesis in
Ikka-deﬁcient mice
The oligomeric IKK complex is composed of two catalytic
subunits, IKKa and IKKb (DiDonato et al, 1997; Mercurio
et al, 1997; Woronicz et al, 1997; Zandi et al, 1997), and a
regulatory subunit named IKKg or NEMO (nuclear factor kB
(NF-kB) essential modulator) (Rothwarf et al, 1998; Yamaoka
et al, 1998). This complex is the key mediator of NF-kB
activation in response to proinﬂammatory and innate im-
mune challenges (Rothwarf et al, 1998). Although IKKa and
IKKb share considerable sequence identity, it is IKKb that
usually serves the more critical function in the activation of
classical NF-kB signalling (Tanaka et al, 1999; Li et al,
1999b,c). To determine the unique functions of IKKa, several
groups have disrupted the Ikka locus in mice and were
surprised to ﬁnd that it has an essential function in epidermal
differentiation and morphogenesis (Hu et al, 1999; Li et al,
1999a; Takeda et al, 1999). Newborn Ikka
–/– mice present
with multiple morphological defects, including shiny and
translucent skin, absence of erupted whiskers, shortened
limbs and truncated snout and tail (Figure 1) (Hu et al,
1999; Takeda et al, 1999; Yoshida et al, 2000). These mice
develop to term but die shortly after birth, probably as a
consequence of a major skin barrier defect that results in
severe dehydration.
The Ikka
–/– epidermis is characterized by the presence of
basal and suprabasal layers, both in a highly proliferative
state, and complete absence of the granular and the corniﬁed
layers (Figure 2A) (Hu et al, 1999; Takeda et al, 1999). At the
molecular level, these anomalies are characterized by the
expression of CK5 and CK14 as well as proliferating cell
markers, such as CK6, PCNA (proliferating cell nuclear anti-
gen) and Ki67 in basal and suprabasal layers (Hu et al, 1999;
Takeda et al, 1999). In contrast, CK1 and CK10 are appro-
priately expressed in the ﬁrst suprabasal layers of the Ikka
–/–
epidermis (Hu et al, 1999; Takeda et al, 1999). Involucrin is
also synthesized in the upper part of the suprabasal layer of
these mice (Takeda et al, 1999), indicating that an early step
in the differentiation process still takes place, although late
terminal differentiation markers, including loricrin and ﬁlag-
grin, are not expressed (Hu et al, 1999; Takeda et al, 1999)
(Figure 2B). It was suggested that the highly proliferative
suprabasal cells of the Ikka
–/– epidermis, which express CK1
and CK10, are reminiscent of intermediate cells rather than
spinous cells (Koster and Roop, 2007). Hence, the most
critical function of IKKa may be induction of cell cycle exit
needed for converting basal and intermediate keratinocytes to
spinous cells. When this step fails, all subsequent differentia-
tion states are aborted (Figure 3).
Nuclear IKKa controls terminal
differentiation of keratinocytes
Control of epidermal proliferation and differentiation by IKKa
does not involve its protein kinase function and is completely
independent from NF-kB activation (Hu et al, 2001). Ikka
–/–
keratinocytes do not exhibit a primary defect in NF-kB
activation (Hu et al, 1999; Takeda et al, 1999). In contrast,
Ikka
–/– keratinocytes display higher IKK and NF-kB activities
than wild-type (WT) cells after incubation with either tumour
necrosis factor-a or interleukin-1 (Hu et al, 2001). The
observations that transgenic mice overexpressing a dominant
inhibitor of NF-kB function (IkBaM) in the epidermis or mice
lacking both RelA and c-Rel display epidermal hyperplasia
that does not disrupt terminal differentiation and stratum
corneum formation (Seitz et al, 1998; Gugasyan et al, 2004;
Zhang et al, 2004), are consistent with the NF-kB-indepen-
dent action of IKKa in the epidermis.
As observed in vivo, isolated Ikka
–/– keratinocytes are
hyperproliferative and do not respond to differentiation-
inducing signals such as conﬂuence or high Ca
2þ (Hu et al,
1999, 2001). Ikka
–/– keratinocytes, however, do differentiate
in vitro when transduced by an adenovirus expressing a
‘kinase-dead’ form of IKKa, indicating that the kinase func-
tion is dispensable for keratinocyte differentiation (Hu et al,
2001). Instead, IKKa needs to enter the nucleus to induce
keratinocyte cell cycle arrest and terminal differentiation
(Sil et al, 2004). Nuclear entry depends on a nuclear localiza-
tion sequence (NLS) within the IKKa kinase domain, the
disruption of which prevents the induction of keratinocyte
Figure 1 Macroscopical presentation of WTand Ikka
–/– mice.
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which cannot substitute for IKKa in keratinocyte differentia-
tion and growth arrest. IKKa is also nuclear in basal and
suprabasal cells of the epidermis (Descargues et al, 2008) and
the oral epithelium (Maeda et al, 2007), ﬁndings that are
consistent with the cell culture results.
The function of IKKa in the keratinocyte nucleus is linked
to the production of a yet-to-be identiﬁed soluble factor or
group of factors termed keratinocyte differentiation-inducing
factor (kDIF) that can induce the expression of terminal
differentiation markers, even in Ikka
–/– cells (Hu et al,
2001). Consistent with the existence of kDIF, transplantation
of Ikka
–/– skin onto the back of immuodeﬁcient WT mice
allows the Ikka-deﬁcient epidermis to undergo normal differ-
entiation, suggesting that the requirement for IKKa can be
bypassed by factors produced by normal skin (Hu et al,
2001). These experiments do not exclude the possibility
that another important source of kDIF or similarly acting
factors are dermal ﬁbroblasts, which are well known to
produce factors that control epidermal morphogenesis
(Wessells, 1977). In support of this hypothesis, a keratino-
cyte-speciﬁc Ikka disruption results in a less severe epidermal
differentiation defect with altered skin barrier function than
the total Ikka knockout (Gareus et al, 2007). These results
were interpreted to suggest that Ikka functions non-autono-
mously in the dermis to control epidermal differentiation.
However, Ikka-deﬁcient keratinocytes from the epidermal-
speciﬁc knockout mouse still fail to differentiate in vitro
Figure 2 (A) Haematoxylin and eosin staining of skin sections from WTand Ikka
–/– mice. (B) Schematic representation of normal and Ikka-
deﬁcient epidermis with expression proﬁle of molecular markers of proliferation and differentiation (BL: basal layer; SP: spinous layer;
GR: granular layer; SC: stratum corneum; hf: hair follicle; de: dermis; magniﬁcation  100 in (A)).
Figure 3 Schematic representation of epidermal development stages.
We propose that the main function of IKKa is to induce cell cycle exit
of intermediate keratinocytes when they mature into spinous cells.
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knockout mice (Hu et al, 2001). Collectively, these results
indicate that IKKa functions within epidermal keratinocytes
and probably in dermal ﬁbroblasts to induce keratinocyte
differentiation. As keratinocyte-restricted expression of IKKa,
unlike the keratinocyte-speciﬁc knockout, does not result in a
differentiation defect (Sil et al, 2004), it appears that the
keratinocyte is the major site of IKKa action with respect to
keratinocyte differentiation and epidermal-directed morpho-
genetic events.
IKKa is a critical component of a
Smad4-independent TGFb–Smad2/3
signalling pathway
The most immediate effect of IKKa re-expression in Ikka
–/–
keratinocytes is cell cycle withdrawal, which precedes the
expression of differentiation markers (Hu et al, 2001). Thus,
to understand the molecular function of IKKa, we searched
for cell cycle-related target genes, the expression of which is
IKKa dependent. This search netted several genes encoding
negative cell cycle regulators, the expression of which is
downregulated in Ikka
–/– keratinocytes and epidermis,
including Mad1 and Ovol1 (Descargues et al, 2008), which
encode negative regulators of Myc. The c-Myc oncogene is
thought to inﬂuence the balance between keratinocyte pro-
liferation and differentiation, depending on the intensity and
timing of its activity (Watt et al, 2008). Mad1 is a basic
region/helix-loop-helix/leucine zipper transcriptional regula-
tor that dimerizes with Max to form Mad:Max heterodimers
that antagonize the transcriptional function of Myc:Max
dimers (Ayer et al, 1993; Grandori et al, 2000). Mad1
–/–
mice, however, are viable, phenotypically normal (Foley
et al, 1998; Grandori et al, 2000) and do not show any
epidermal defect. Most likely, other Mad genes, including
Mad2, Mad3 and Mad4, are functionally redundant with
Mad1 and compensate for its loss. Indeed Mad2 and Mad3
are also induced in keratinocytes in an IKKa-dependent
manner (unpublished data). Ovol1 is a zinc-ﬁnger-containing
transcription factor, which, similar to Mad1, is also expressed
in differentiating suprabasal keratinocytes (Dai et al, 1998;
Descargues et al, 2008). Ovol1
–/– adult mice present with
aberrant hair formation but normal epidermal differentiation
(Dai et al, 1998). However, the suprabasal epidermis of
Ovol1
–/– embryos shows increased proliferation and
in vitro, Ovol1
–/– keratinocytes fail to exit the cell cycle in
response to growth-inhibitory signals, such as high Ca
2þ or
TGFb (Nair et al, 2006). This defect may be explained in part
by abnormal upregulation of c-Myc, which is a direct target of
Ovol1 in keratinocytes (Nair et al, 2006). Thus, IKKa controls
keratinocyte proliferation and cycling through the regulation
of several Myc antagonists to allow keratinocytes to embark
on their differentiation pathway (Figure 4). Interestingly,
another TGFb-related mechanism involving Smad3/4 and
E2F4/5 transcription factors has been shown earlier to
directly inhibit c-Myc expression in keratinocytes (Chen
et al, 2002) (Figure 4). Although this signalling pathway
triggers antiproliferative effects of TGFb in keratinocytes, its
impact on keratinocyte differentiation is unknown.
Mad1 and Ovol1 are involved in the inhibition of
keratinocyte proliferation induced by TGFb family members
(Vastrik et al, 1995; Gomis et al, 2006), suggesting a link
between IKKa and the TGFb signalling pathway. TGFb family
members, including TGFbs, activins and BMPs, are cytokines
that control cell growth, differentiation and deposition of
extracellular matrix through binding to heterodimeric cell
surface receptor complexes composed of type I and II sub-
units, and intracellular Smad transcription factors (Shi and
Massague, 2003; Feng and Derynck, 2005; Schmierer and Hill,
2007). The eight mammalian Smad proteins are divided into
three distinct groups: receptor-activated Smads (R-Smads:
Smad1, Smad2, Smad3, Smad5 and Smad8), a unique
common Smad mediator (Co-Smads: Smad4) and inhibitory
Smads (i-Smads: Smad6 and Smad7). On ligand binding,
the type II receptor activates the type I receptor through its
kinase domain, and the type I receptor in turn phosphorylates
R-Smads. The activated R-Smads form heterodimeric com-
plexes with Smad4, which accumulate in the nucleus and
directly repress or activate speciﬁc target genes (Shi and
Massague, 2003; Feng and Derynck, 2005; Schmierer and
Hill, 2007).
TGFb family members, their receptors and Smad transcrip-
tion factors are abundantly expressed in epidermal keratino-
cytes, suggesting homoeostatic and regulatory functions
(He et al, 2001; Li et al, 2003). Phosphorylated Smad2 and
Smad3 proteins are concentrated in the nuclei of basal and
suprabasal keratinocytes, whereas nuclear Smad4 staining
is more preeminent in basal cells (Descargues et al, 2008).
Nonetheless, alterations of TGFb signalling in transgenic/
knockout mice have often resulted only in minor epidermal
defects, thereby obscuring its exact functions in this tissue
(Li et al, 2003). We recently found that IKKa interacts strongly
with Smad3 and weakly with Smad2, but does not bind
Smad4 (Descargues et al, 2008). IKKa associates with the
C-terminal MH2 domain of Smad3 through its kinase domain
(unpublished observations). The R-Smad MH2 domain is
known to be essential for trans-activation, phosphorylation
by type I receptors and Smad4 binding (Massague, 2000; Feng
and Derynck, 2005). On stimulation by TGFb1, IKKa and
Smad3 form a transcriptional complex that accumulates in
the keratinocyte nucleus to directly control the transcription
of Mad1 (Descargues et al, 2008). Similar ﬁndings were made
Figure 4 TGFb-related signalling pathway controlling Myc activity
in keratinocytes. The IKKa–Smad2/3 axis induces Mad1 and Ovol 1
expression on TGFb stimulation. These proteins may inhibit the
activity and expression of Myc, inducing in turn keratinocyte cycle
exit and differentiation. Interestingly, a TGFb–Smad3/4 signalling
pathway, which is not associated with IKKa, but functions in
cooperation with E2F4/5 transcription factors, has also been
shown to negatively control c-Myc expression in keratinocytes
(Chen et al, 2002).
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–/– keratinocytes stimu-
lated with TGFb1, Smad3 is no longer recruited to the Mad1
regulatory region despite its normal association with Smad4.
Furthermore, nuclear staining for activated Smad2 and
Smad3 is dramatically diminished in the Ikka
–/– epidermis
(Descargues et al, 2008). Taken together, these results indi-
cate that IKKa is required for nuclear accumulation and
chromatin recruitment of phosphorylated Smad2 and
Smad3 to IKKa-regulated genes in response to TGFb1.
Interestingly, activin A, an important regulator of epidermal
differentiation (Owens et al, 2008), is involved in the induc-
tion of Mad1 expression in keratinocytes (Werner et al, 2001).
As a result, one may speculate that the IKKa–Smad2/3
complex forms and activates anti-Myc genes, including
Mad1, on activin A signals. As activin A also downregulates
the Id1, Id2 and Id3 genes in keratinocytes (Rotzer et al,
2006), it could also be interesting to analyse whether this
signalling pathway depends on IKKa. Finally, we found that
kDIF functions downstream of the IKKa–Smad2/3 signalling
pathway as it can induce differentiation of Ikka
–/– keratino-
cytes without inducing Mad1 expression (Figure 5). Exactly
how kDIF functions and what it is composed of remain to be
determined.
The results mentioned above provided the ﬁrst clear
evidence for a critical function for Smad transcription factors
in epidermal differentiation. Although Smad3 deﬁciency
alone does not result in any cutaneous defect (Zhu et al,
1998; Datto et al, 1999; Yang et al, 1999) and the loss of
Smad2 leads to early embryonic lethality (Nomura and Li,
1998; Waldrip et al, 1998; Weinstein et al, 1998; Heyer et al,
1999), loricrin and ﬁlaggrin expression is barely detectable in
E15.5 embryos lacking both Smad3 alleles and one Smad2
allele in their epidermis (Descargues et al, 2008). Similarly,
siRNA-mediated Smad2 knockdown in Smad3-deﬁcient ker-
atinocytes inhibited the expression of loricrin and ﬁlaggrin,
as well as Mad1, in response to high Ca
2þ (Descargues et al,
2008). These results suggest that Smad2 and Smad3 are
functionally redundant. The importance of the TGFb–
Smad2/3–IKKa axis for proper epidermal differentiation is
also underscored by the analysis of transgenic mice in which
the i-Smad Smad7 is inducibly expressed in the epidermis,
resulting in defective expression of loricrin and ﬁlaggrin and
failed stratum corneum formation (Descargues et al, 2008).
Consequently, these mutant mice display epidermal hyper-
plasia due to abnormal proliferation of suprabasal keratino-
cytes and loss of nuclear IKKa and Mad1 (Descargues et al,
2008).
Surprisingly, this new TGFb response pathway centred
around Smad2/3–IKKa complex formation is independent
of Smad4. Smad4-deﬁcient keratinocytes display normal
Mad1 expression (Descargues et al, 2008) and undergo
terminal differentiation in response to high Ca
2þ (unpub-
lished data). These results are consistent with the phenotype
of mice with epidermal-speciﬁc deletion of Smad4 (Smad4
D/D
mice). These mice present with degeneration of hair follicles
and dermal cysts that progress to skin tumours in old
animals, but do not show any perturbated epidermal differ-
entiation and stratum corneum formation (Yang et al, 2005;
Qiao et al, 2006). Furthermore, activated Smad2 and Smad3,
as well as IKKa, are normally localized in the nuclei of
Smad4
D/D keratinocytes, which display normal Mad1 expres-
sion (Descargues et al, 2008). Taken together, these results
strongly indicate that Smad4 is not required for epidermal
differentiation. The Smad4 independence of the TGFb–
Smad2/3–IKKa signalling pathway is reminiscent of another
TGFb signalling operative during erythroid development in
which TIF1g (also called TRIM33 or ectodermin) replaces
Smad4 (He et al, 2006). However, TIF1g is a RING-type
ubiquitin ligase that can target Smad4 to degradation and
can therefore function as a negative regulator of Smad4-
dependent TGFb signalling (Dupont et al, 2005). Hence the
exact function of TIF1g in TGFb signalling is not fully under-
stood, and it is not known whether it affects the IKKa-
dependent pathway.
IKKa and squamous cell carcinoma
IKKa was recently identiﬁed as a tumour suppressor in
squamous cell carcinoma (SCC) (Liu et al, 2006; Maeda
et al, 2007). SCC is a cancer derived from squamous epithelia
of the skin (epidermis), head and neck tissues (mouth,
throat, oral and nasal cavities, esophagus) as well as other
sites. SCC is the second most common skin cancer in
Caucasians with an estimated incidence of 100000–150000
new cases per year in the United States (Johnson et al, 1992).
Sun exposure and immune suppression increase the risk of
SCC development and so does tobacco use (Rudolph and
Zelac, 2004; Hampton, 2005). SCC of the oral cavity is one of
the most prevalent cancers of the head and neck region with a
worldwide incidence of 300000 new cases per year, the
Figure 5 Mad1 expression is not induced by kDIF-mediated kera-
tinocyte differentiation. Conditioned medium from WT keratino-
cytes, which contains kDIF as shown earlier (Hu et al, 2001), failed
to induce Mad1 expression in Ikka
–/– keratinocytes while leading to
keratinocyte differentiation as indicated by ﬁlaggrin expression.
Only the re-expression of IKKa in Ikka
–/– keratinocytes infected
with adenovirus encoding this protein (Ad-IKKa) induces Mad1
expression.
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chewing (Silverman, 2001). SCCs of the oral cavity are more
aggressive than those developing from the skin, and are
associated with a 5-year survival rate of about 50–55%
(Silverman, 2001).
Molecular changes in SCCs are characterized by a marked
heterogeneity and include activation of oncogenes, such as
RAS, MYC, EGFR and Cyclin D1, as well inactivation of
tumour suppressors, including p53 and p16 (Hardisson,
2003). These genetic alterations are thought to inﬂuence
malignant keratinocyte behaviour and tumour progression,
but the precise molecular pathogenesis of SCC is poorly
understood. Interestingly, mutations in exon 15 of the IKKa
locus were described in a few high-grade and poorly differ-
entiated human SCCs of the skin and were shown to be
associated with reduced IKKa expression (Liu et al, 2006).
However, it seems that downregulation of IKKa due to
epigenetic silencing of the IKKa locus is a more common
occurrence seen in close to 30% of invasive oral SCCs (Maeda
et al, 2007). It was also reported that overexpression of IKKa
in the suprabasal compartment, which results in increased
epidermal differentiation and reduced keratinocyte prolifer-
ation, inhibits chemically induced SCC formation and pro-
gression in mice (Liu et al, 2006). These results, together with
enhanced SCC incidence in Ikka
þ/– mice subjected to two-
stage skin carcinogenesis and loss of Ikka heterozygosity in
the tumours, provide evidence that IKKa is a tumour sup-
pressor in the epidermis (Liu et al, 2006; Park et al, 2007).
This function of IKKa is probably mediated through the
control of keratinocyte proliferation. The loss of nuclear
IKKa contributes to malignant conversion of keratinocytes
into less differentiated and proliferative carcinoma cells.
However, a recent study has suggested that increased IKKa
may be found in acantholytic SCC (ASCC) (Moreno-
Maldonado et al, 2008), an histologic variant of SCC showing
positive staining for CKs (Rinker et al, 2001). Unfortunately,
the authors of that study have not carefully analysed whether
ASCCs present with loss of nuclear IKKa, which would make
their results more consistent with other studies mentioned
above.
SCC and other carcinoma cells are known to overproduce
TGFb1 to modify their microenvironment through local im-
munosupression, extracellular matrix remodelling and
neoangiogenesis, and these changes are required for tumour
progression and invasiveness (Oft et al, 1996, 1998; Siegel
and Massague, 2003; Li et al, 2005a, 2006). At the same time,
carcinoma cells become resistant to TGFb-induced growth
arrest (Siegel and Massague, 2003; Li et al, 2005a, 2006).
Altered IKKa function may contribute, at least in part, to
acquired resistance to TGFb1-induced growth arrest.
Conclusions and future directions
Although IKKa was ﬁrst identiﬁed as a catalytic subunit of the
IKK complex, which mediates NF-kB activation (DiDonato
et al, 1997; Mercurio et al, 1997; Regnier et al, 1997; Zandi
et al, 1997), it has quickly emerged as a multifunctional
protein with several unexpected and surprising activities. In
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Figure 6 (A) In the canonical TGFb signalling pathway, ligands signal through type I and II transmembrane protein kinase receptors. After
TGFb binding, type II receptor recruits and phosphorylates type I receptor, which in turn activates R-Smads. Phosphorylated R-Smads
oligomerize with the co-Smad Smad4 and accumulate in the nucleus where they interact with DNA and transcription factors to regulate the
expression of target genes. (B) During epidermal terminal differentiation, TGFb1 stimulation of keratinocytes induces the formation of a
complex between activated Smad2/3 and IKKa. This complex accumulates in keratinocyte nuclei independently of the presence of Smad4 and
controls the transcriptional activation of Mad1 and Ovol1 probably with the cooperation of other transcription factors such as IRF6. The Smad4-
independent TGFb–Smad2/3–IKKa axis is required for cell cycle exit and induction of terminal differentiation of keratinocytes.
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keratinocyte proliferation, differentiation and oncogenic
transformation, and this function is completely unrelated to
its protein kinase activity or NF-kB signalling. Instead, IKKa
functions as a cofactor for Smad2/3 in a Smad4-independent
pathway that inhibits keratinocytes proliferation (Descargues
et al, 2008) (Figure 6). In this capacity, IKKa is required for
the induction of a speciﬁc subset of TGFb-responsive genes
that include the Myc antagonists Mad1 and Ovol1, but is not
needed for other well-known TGFb target genes, such as p21,
p15 and p27, encoding inhibitors of cyclin-dependent kinases
(CDKs) (Descargues et al, 2008). This is reminiscent of the
two different classes of antiproliferative gene responses: Myc
repression and inhibition of CDKs, respectively, that are
induced during TGFb-mediated cell cycle arrest (Massague
et al, 2000). It is attractive to speculate that the tumour
suppressive function of IKKa is exerted through this pathway
as well.
Other proteins may be part of the TGFb–Smad2/3–IKKa
signalling pathway, as revealed by two mouse models with
functional alterations of 14-3-3s (repeated epilation mutant
mice) and IRF6, the disruption of which faithfully mimics the
phenotype of Ikka
–/– mice (Herron et al, 2005; Li et al, 2005b;
Ingraham et al, 2006; Richardson et al, 2006). 14-3-3s
belongs to a family of adaptors that can interact with target
proteins in a sequence-speciﬁc manner, although its exact
function is poorly understood (Mhawech, 2005). It was
reported that IKKa may protect the 14-3-3s locus from
hypermethylation in keratinocytes by interacting with histone
H3 (Zhu et al, 2007). In that study, the authors showed that
14-3-3s is downregulated in Ikka
–/– keratinocytes, suggesting
that this gene is a downstream target of IKKa (Zhu et al,
2007). The human IRF6 locus is defective in Van der Woude
(VWS, OMIM: 119300) and popliteal pterygium (PPS, OMIM:
11500) syndromes, which are characterized by orofacial
defects such as cleft lip and palate (Kondo et al, 2002).
IRF6 belongs to a family of transcription factors that share
a highly conserved helix-turn-helix DNA-binding domain and
a less conserved protein-binding domain. Interestingly, this
protein-binding domain is related to the C-terminal MH2
domain of Smad proteins and has been referred to SMIR
(Smad and IRF) domain (Eroshkin and Mushegian, 1999). As
DNA binding by Smad transcription factors depends on their
association with other DNA-bound transcription factors
(Derynck and Zhang, 2003; ten Dijke and Hill, 2004), one
can speculate that IRF6 may be a component of the Smad2/3–
IKKa transcriptional complex that accumulates in the kerati-
nocyte nucleus to induce the obligatory cell cycle exit that
precedes terminal differentiation (Figure 6). In addition, IKKa
may also interact with other transcription factors, such as
RARs to control epidermal barrier formation (Gareus et al,
2007). The identiﬁcation of other IKKa-interacting proteins
and additional IKKa target genes will provide an ever better
understanding of how this critical regulator of epidermal
proliferation and differentiation carries out its daily work.
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